DE1483873U - - Google Patents

Info

Publication number
DE1483873U
DE1483873U DENDAT1483873D DE1483873DU DE1483873U DE 1483873 U DE1483873 U DE 1483873U DE NDAT1483873 D DENDAT1483873 D DE NDAT1483873D DE 1483873D U DE1483873D U DE 1483873DU DE 1483873 U DE1483873 U DE 1483873U
Authority
DE
Germany
Prior art keywords
far
der
ßmobwma
zyllzdrloobe
wwlch
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DENDAT1483873D
Other languages
German (de)
English (en)
Publication of DE1483873U publication Critical patent/DE1483873U/de
Active legal-status Critical Current

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DENDAT1483873D Active DE1483873U (https=)

Publications (1)

Publication Number Publication Date
DE1483873U true DE1483873U (https=)

Family

ID=789116

Family Applications (1)

Application Number Title Priority Date Filing Date
DENDAT1483873D Active DE1483873U (https=)

Country Status (1)

Country Link
DE (1) DE1483873U (https=)

Similar Documents

Publication Publication Date Title
Seymour et al. Venetoclax plus rituximab in relapsed or refractory chronic lymphocytic leukaemia: a phase 1b study
Altarac et al. Use of D-mannose in prophylaxis of recurrent urinary tract infections (UTIs) in women
Wolff et al. In vitro pharmacodynamic evaluation of VP-16-213 and implications for chemotherapy
DE1483873U (https=)
Sugimoto et al. Randomized phase II trial of S-1 plus irinotecan versus S-1 plus paclitaxel as first-line treatment for advanced gastric cancer (OGSG0402)
EP4445953A3 (en) Levodopa infusion solution
CN107568265A (zh) 一种塑料用银‑稀土复合抗菌剂
SA121420345B1 (ar) طريقة تحضير الجسيمات النانوية الفضية الحيوية
WO2010139942A3 (en) Nanoparticle for biomolecule delivery
Gordon et al. Bimekizumab maintenance of response from the end of pivotal trials through 4 years: Results in patients with moderate to severe plaque psoriasis from BE BRIGHT
JP2018537542A (ja) 消臭用化粧品組成物及びその製造方法
National Academies of Sciences, Engineering, and Medicine Health literacy and palliative care: Workshop summary
Byambakhishig XXXVIII
Ebrey et al. Antibiotic prophylaxis after swan bite.
Norheim et al. Comparison between participants and non‐participants in a dental health survey in Northern Norway
Verner et al. Response Rates and Quality of Life Outcomes in Australasian Leukaemia & Lymphoma Group NHL29: A Phase II Study of Ibrutinib, Rituximab and Mini-CHOP in Very Elderly Patients with Newly Diagnosed Diffuse Large B Cell Lymphoma
MADRIGAL et al. THE ROLE OF THE NURSING TEAM OF THE NEUROSCIENCES GROUP OF ANTIOQUIA (GNA) IN THE EXECUTION OF THE PREVENTION CLINICAL TRIAL FOR EARLY-ONSET FAMILIAL ALZHEIMER’S DISEASE IN COLOMBIA
Antikörper et al. Medikamentöse Tumortherapie
Koji et al. Field study: Associations of excessive sleepiness on duty with sleeping hours and number of days of overnight work among medical residents in Japan
Pearce et al. P097 Are patients in rural communities interested in online sexual health services?
Faruque et al. Hunger Reduction in the United States of America: Analysis of Factors Contributing to Hunger
Hanuschek II. 4.2. 10 Eckhard Henscheid
Doubek et al. Hematologické malignity v graviditě
Di Fabio Was wird aus dem Westen?
DE1449992U (https=)